Chemoinformaics analysis of Cycloartane-3,24,25-Triol
| Molecular Weight | 460.743 | nRot | 5 |
| Heavy Atom Molecular Weight | 408.327 | nRig | 22 |
| Exact Molecular Weight | 460.392 | nRing | 5 |
| Solubility: LogS | -3.804 | nHRing | 0 |
| Solubility: LogP | 4.893 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 85 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 87.1792 |
| nHD | 3 | BPOL | 52.1668 |
| QED | 0.449 |
| Synth | 5.536 |
| Natural Product Likeliness | 3.202 |
| NR-PPAR-gamma | 0.178 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.038 |
| Pgp-sub | 0 |
| HIA | 0.022 |
| CACO-2 | -4.889 |
| MDCK | 0.0000168 |
| BBB | 0.655 |
| PPB | 0.988055 |
| VDSS | 1.385 |
| FU | 0.0229466 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.258 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.938 |
| CYP2c9-inh | 0.079 |
| CYP2c9-sub | 0.386 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.487 |
| CYP3a4-inh | 0.251 |
| CYP3a4-sub | 0.354 |
| CL | 10.651 |
| T12 | 0.024 |
| hERG | 0.041 |
| Ames | 0.026 |
| ROA | 0.099 |
| SkinSen | 0.223 |
| Carcinogencity | 0.014 |
| EI | 0.016 |
| Respiratory | 0.894 |
| NR-Aromatase | 0.606 |
| Antiviral | Yes |
| Prediction | 0.569258 |